Bone Biologics annual net profit margin
2019
2020
Bone Biologics Net Profit Margin Growth & History (BBLG)
Bone Biologics's net profit margin was −0.17% for fiscal 2020.
View full Bone Biologics company overviewBone Biologics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −0.17% | +0.15 pp |
| 2019 | 2019-12-31 | −0.32% | — |
Bone Biologics quarterly net profit margin
Q1.20
Q1.21
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q1 2021 | 2021-03-31 | −0.04% | +0.02 pp |
| Q1 2020 | 2020-03-31 | −0.06% | — |
Bone Biologics net profit margin trends
Between the periods ended 2019-12-31 and 2020-12-31, Bone Biologics's net profit margin increased from −0.32% to −0.17%, a change of +0.15 percentage points. The latest reported quarter, Q1 2021, shows −0.04%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bone Biologics source filings ↗